Table 1.
UTD A and P classification [4]
| UTD A Classification system for antenatal presentation of UTD | |
|---|---|
| Risk category | Criteria |
| UTD A Normal | A Normal urinary tract is described as the one with no urinary tract abnormalities and anteroposterior renal pelvic diameter (APRPD) measuring less than 4 mm between 16 and 27 weeks’ gestation and less than 7 mm pelvic dilation at 28 or more weeks of gestation. |
| UTD A1(low risk) | A normal urinary tract with 4 to less than 7 mm pelvic dilation at 16–27 weeks’ gestation or 7 to less than 10 mm at 28 or more weeks of gestation with or without central calyceal dilation. |
| UTD A2–3 (increased risk) | Includes foetuses with APRPD of 7 mm or more between 16 and 27 weeks’ gestation or 10 mm or greater at 28 weeks of gestation, peripheral calyceal dilation, ureteral dilation, renal parenchymal, or bladder abnormalities. |
| UTD P Classification system for postnatal presentation of UTD | |
|---|---|
| Risk category | Criteria |
| UTD P Normal | A normal urinary tract is described as the one with no urinary tract abnormalities and APRPD less than 10 mm. |
| UTD P1 (low risk) | Describes a normal urinary tract with APRPD 10 to less than 15 mm or central calyceal dilation. |
| UTD P2 (intermediate risk) | Describes APRPD 15 mm or more or peripheral calyceal dilation. |
| UTD P3 (high risk) | Describes additional ureteral dilation, abnormal renal echogenicity, or cysts or bladder abnormalities regardless of APRPD measurement. |